Arlington Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.9K Sell
501
-183
-27% -$16K ﹤0.01% 284
2026
Q1
$58.3K Buy
684
+14
+2% +$1.25K 0.01% 210
2025
Q4
$52.9K Sell
670
-2,138
-76% -$168K 0.01% 196
2025
Q3
$224K Buy
2,808
+249
+10% +$21.2K 0.04% 164
2025
Q2
$233K Buy
2,559
+90
+4% +$8.22K 0.05% 159
2025
Q1
$231K Sell
2,469
-1,345
-35% -$120K 0.05% 160
2024
Q4
$347K Buy
3,814
+868
+29% +$82.8K 0.07% 118
2024
Q3
$306K Hold
2,946
0.07% 128
2024
Q2
$286K Buy
2,946
+2,276
+340% +$210K 0.07% 124
2024
Q1
$60.3K Sell
670
-30
-4% -$2.54K 0.02% 269
2023
Q4
$55.8K Buy
+700
New +$52.6K 0.02% 276

Other funds holding CL

Arlington Trust's CL Position: Q2 2026 in Review

Arlington Trust reduced its Colgate-Palmolive (CL) stake by 27% in Q2 2026, selling an estimated $16K and leaving 501 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #284.

Arlington Trust first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $347K in Q4 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Arlington Trust held 501 shares of Colgate-Palmolive worth $45.9K as of Q2 2026.
  • Arlington Trust sold 183 Colgate-Palmolive shares in Q2 2026, an estimated $16K.
  • Colgate-Palmolive made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #284 holding.
  • Arlington Trust first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Arlington Trust's Colgate-Palmolive position peaked at $347K in Q4 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.